Literature DB >> 12712405

Nuclear matrix proteins changes in cancerous prostate tissues and their prognostic value in clinically localized prostate cancer.

Francesco Boccardo1, Alessandra Rubagotti, Giorgio Carmignani, Andrea Romagnoli, Guido Nicolò, Paola Barboro, Silvio Parodi, Eligio Patrone, Cecilia Balbi.   

Abstract

BACKGROUND: After the discovery that nuclear matrix (NM) directs the spatial organization of DNA transcription and replication, there has been an increasing interest in studying NM changes associated with malignant transformation and their potential usefulness in the clinical setting.
METHODS: High-resolution two-dimensional gel electrophoresis was used to analyze the NM proteins (NMP) of specimens of prostate cancer tissue obtained from the prostates of 75 patients undergoing retropubic prostatectomy.
RESULTS: Nine NMP with different molecular weights and isoelectric points have been identified. They were expressed differently by prostate cancer tissues. An increasing trend toward the expression of such proteins like NMP 6-8 was evident with increasing tumor stage and dedifferentiation. NMP 6-8 were also significantly correlated with the risk of biochemical progression. However, Gleason score was the only significant discriminant in this regard in multiparametric models.
CONCLUSIONS: This study confirms that prostate cancer progression is related to profound changes in NMP expression patterns. However, due to the complexity of the methods required to define these latter, the clinical relevance of NMP appears to be still limited. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12712405     DOI: 10.1002/pros.10248

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  8 in total

1.  Molecular alterations in primary prostate cancer after androgen ablation therapy.

Authors:  Carolyn J M Best; John W Gillespie; Yajun Yi; Gadisetti V R Chandramouli; Mark A Perlmutter; Yvonne Gathright; Heidi S Erickson; Lauren Georgevich; Michael A Tangrea; Paul H Duray; Sergio González; Alfredo Velasco; W Marston Linehan; Robert J Matusik; Douglas K Price; William D Figg; Michael R Emmert-Buck; Rodrigo F Chuaqui
Journal:  Clin Cancer Res       Date:  2005-10-01       Impact factor: 12.531

2.  Dynamic SUMOylation is linked to the activity cycles of androgen receptor in the cell nucleus.

Authors:  Miia Rytinki; Sanna Kaikkonen; Päivi Sutinen; Ville Paakinaho; Vesa Rahkama; Jorma J Palvimo
Journal:  Mol Cell Biol       Date:  2012-08-13       Impact factor: 4.272

3.  Prognostic value of nuclear matrix protein expression in localized prostate cancer.

Authors:  Francesco Ricci; Alessandra Rubagotti; Linda Zinoli; Rosa Mangerini; Pier Vitale Nuzzo; Giorgio Carmignani; Alchiede Simonato; Paola Barboro; Cecilia Balbi; Francesco Boccardo
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-10       Impact factor: 4.553

Review 4.  Mechanics of the nucleus.

Authors:  Jan Lammerding
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

5.  Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death.

Authors:  Pier Vitale Nuzzo; Alessandra Rubagotti; Linda Zinoli; Francesco Ricci; Sandra Salvi; Simona Boccardo; Francesco Boccardo
Journal:  BMC Cancer       Date:  2012-12-28       Impact factor: 4.430

6.  Serum early prostate cancer antigen (EPCA) level and its association with disease progression in prostate cancer in a Chinese population.

Authors:  Zhigang Zhao; Wenjing Ma; Guohua Zeng; Defeng Qi; Lili Ou; Yeping Liang
Journal:  PLoS One       Date:  2011-05-03       Impact factor: 3.240

7.  Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer.

Authors:  P Barboro; E Repaci; A Rubagotti; S Salvi; S Boccardo; B Spina; M Truini; C Introini; P Puppo; N Ferrari; G Carmignani; F Boccardo; C Balbi
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

8.  Androgen receptor activity is affected by both nuclear matrix localization and the phosphorylation status of the heterogeneous nuclear ribonucleoprotein K in anti-androgen-treated LNCaP cells.

Authors:  Paola Barboro; Luana Borzì; Erica Repaci; Nicoletta Ferrari; Cecilia Balbi
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.